- Home
- PRTA vs CAN Comparison
PRTA vs CAN Comparison
Compare PRTA & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRTA | CAN |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | Ireland | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.1M | 511.2M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | PRTA | CAN |
|---|---|---|
| Price | $10.73 | $1.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $17.71 | $3.64 |
| AVG Volume (30 Days) | 578.4K | ★ 34.9M |
| Earning Date | 11-06-2025 | 11-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $11,786,000.00 | ★ $422,228,000.00 |
| Revenue This Year | N/A | $78.34 |
| Revenue Next Year | $672.02 | $50.58 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 83.87 |
| 52 Week Low | $4.32 | $0.53 |
| 52 Week High | $17.66 | $3.27 |
Technical Indicators
Market Signals| Indicator | PRTA | CAN |
|---|---|---|
| Relative Strength Index (RSI) | 57.52 | 46.39 |
| Support Level | $9.90 | $0.89 |
| Resistance Level | $10.91 | $0.99 |
| Average True Range (ATR) | 0.53 | 0.11 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 72.39 | 41.76 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.